Stepan CO 10-Q quarterly reports
Quarterly reports, with unaudited financial statements and management’s discussion of the quarter just ended.
NYSE
SCL
Stepan COStepan Company announced a substantial increase in net sales and operating income for the second quarter of 2026, driven by higher selling prices and sales volumes across its segments.
NYSE
SCL
Stepan COStepan Company reported a net loss of $41.4 million for the first quarter of 2026, primarily due to a significant business restructuring charge, despite a slight increase in net sales.
NYSE
SCL
Stepan COStepan Company reports a significant drop in Q3 net income and diluted EPS, primarily driven by lower surfactant profitability and higher interest expenses, despite overall sales growth.
NYSE
SCL
Stepan COStepan Company reported a 19% increase in second-quarter net income to $11.3 million, with net sales growing 7% to $594.7 million, driven by higher selling prices and sales volume.
NYSE
SCL
Stepan COStepan Company's first quarter 2025 results show an increase in net sales and earnings per share compared to the same period last year, driven by higher average selling prices and sales volumes.
NYSE
SCL
Stepan COStepan Company's third-quarter earnings per share rose to $1.03, despite a slight decrease in net sales compared to the same period last year.
NYSE
SCL
Stepan CO10-Q: Stepan Company Reports Mixed Q2 Results Amidst Operational Challenges and Social Engineering Scheme
Stepan Company's second-quarter earnings were impacted by lower selling prices and a social engineering scheme, despite increased sales volumes.
NYSE
SCL
Stepan COStepan Company's first quarter 2024 net income decreased to $13.9 million, or $0.61 per diluted share, compared to $16.1 million, or $0.70 per diluted share, in the same period last year, primarily due to lower average selling prices.